TCG Crossover GP I, LLC 13D/13G Filings for Cogent Biosciences, Inc. (COGT)

TCG Crossover GP I, LLC 13D and 13G filings for Cogent Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-09
4:22 pm
Purchase		 2023-12-31 13G Cogent Biosciences, Inc.
COGT		 TCG Crossover GP I, LLC 5,631,042
6.500%		 2,000,000increase
(+55.08%)		 Filing
2023-02-14
2:23 pm
Purchase		 2022-12-31 13G Cogent Biosciences, Inc.
COGT		 TCG Crossover GP I, LLC 3,631,042
5.200%		 3,631,042increase
(New Position)		 Filing